Format

Send to

Choose Destination
See comment in PubMed Commons below
CNS Spectr. 2012 Nov;17 Suppl 1:10-21. doi: 10.1017/S1092852912000739.

Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.

Author information

  • 1Neuroscience Education Institute, Carlsbad, CA, USA. smstahl@neiglobal.com

Abstract

Antipsychotics are the mainstay of treatment for patients with schizophrenia. However, these medications only work if they are taken and perhaps work best if they are taken for longer periods of time than seen in typical research trials. Here we explore the idea of "time as drug" by reviewing the data showing the potential benefits of long-term antipsychotic use. We also discuss the utility of depot antipsychotic formulations for improving the chances of attaining long-term therapeutic results.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cambridge University Press
    Loading ...
    Write to the Help Desk